Foghorn Therapeutics Inc. (FHTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Foghorn Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.58x | -2.99x | -2.75x | -2.44x | -8.39x | -10.84x |
| P/B Ratio | -3.13x | -5.69x | -3.51x | 2369.23x | 8.78x | 5.10x |
| P/S Ratio | 11.00x | 11.46x | 7.93x | 13.80x | 644.51x | 1734.31x |
| Profitability | ||||||
| Gross Margin | 89.2% | 100.0% | 100.0% | 100.0% | 100.0% | -13322.1% |
| Operating Margin | -265.6% | -454.3% | -315.9% | -609.2% | -7637.1% | -15937.4% |
| Net Margin | -240.3% | -383.2% | -288.2% | -566.3% | -7681.6% | -16000.0% |
| EBITDA Margin | -254.9% | -429.9% | -305.8% | -591.9% | -7292.4% | -15628.8% |
| Liquidity | ||||||
| Current Ratio | 2.73x | 3.73x | 4.11x | 6.37x | 9.44x | 10.12x |
| Quick Ratio | 2.73x | 3.73x | 4.11x | 6.37x | 9.44x | 10.12x |
| Leverage | ||||||
| Debt/Equity | -0.38x | -0.82x | -0.58x | 459.88x | 0.60x | 0.56x |
YoY = year-over-year change. Source: FMP..